FDA issues draft guidance on site changes; Supplier of execution drugs said to be in India;

> Compounder refuses FDA request that it stop making products. Story

> The FDA has issued draft guidance called Manufacturing Site Change Supplements: Content and Submission. Post (PDF)

> BuzzFeed claims they have located a man in India named Chris Harris who has been supplying U.S. states with execution drugs. Story

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.